Evidence map›Paper›PMID 29556134›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2018

Investigation of nepetolide as a novel lead compound: Antioxidant, antimicrobial, cytotoxic, anticancer, anti-inflammatory, analgesic activities and molecular docking evaluation.

Tanzeel Ur Rehman, Arif-Ullah Khan, Azar Abbas, Javid Hussain, Farman Ullah Khan, Kimberly Stieglitz, Shamsher Ali

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Cytotoxic Effects of SomePlants (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Review
  5. Frontiers in pharmacology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Tanzeel Ur RehmanDepartment of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Arif-Ullah KhanDepartment of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Azar AbbasDepartment of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Javid HussainDepartment of Biological Sciences and Chemistry, University of Nizwa, Nizwa 616, Oman.
Farman Ullah KhanDepartment of Chemistry, University of Science and Technology, Bannu, Khyber Pakhtunkhwa, Pakistan.
Kimberly StieglitzSTEM Biotechnology Division, Roxbury Community College, Roxbury, MA, USA.
Shamsher AliCollege of Professional Studies, Northeastern University, 350 Huntington Avenue, Boston, USA.
Riphah International University · PKNortheastern University · USRoxbury Community College · USUniversity of Nizwa · OMUniversity of Science and Technology Bannu · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we describe various pharmacological effects and computational analysis of nepetolide, a tricyclic clerodane-type diterpene, isolated from

Indexed as

AnalgesicAnticancerAnti-inflammatoryAntimicrobialAntioxidantComputational PharmacologyCytotoxicNepetolide

Identifiers

PMID29556134
PMCPMC5856943
OpenAlexW2778464777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.